O-Glycosylation Induces Amyloid-β To Form New Fibril Polymorphs Vulnerable for Degradation

O-Glycosylation Induces Amyloid-β To Form New Fibril Polymorphs Vulnerable for Degradation
复制标题

O-糖基化诱导淀粉样蛋白-β 形成易降解的新原纤维多晶型物。

DOI:
10.1021/jacs.1c08607
复制
发表时间:
2021-12-08
影响因子:
15
通讯作者:
Dong, Suwei
Dong, Suwei
中科院分区:
化学1区
文献类型:
--
作者:
Liu, Dangliang;Wei, Qijia;Dong, Suwei

文献摘要

被引文献

相似文献

在阿尔茨海默病(AD)的进展过程中,大脑中淀粉样蛋白- β (A β)肽的积累(由于生物合成和清除之间的平衡被破坏)发生。A - β肽具有多种翻译后修饰(PTMs),这些修饰以不同的方式调节A - β聚集成原纤维,但了解PTMs在这些过程中的机制作用仍然是一个挑战。在这里,我们化学合成了三种具有Tyr10 o糖基化的A β(1-42)肽的均匀修饰亚型,Tyr10 o糖基化是一种最初从AD患者脑脊液样本中发现的不寻常的PTM。我们发现,多糖显著影响A β的聚集和降解(42)。通过结合冷冻电镜和各种生化分析,我们证明了Gal β 1-3GalNAc修饰重定向a β(42)形成新的纤维多态性结构,该结构不太稳定,更容易受到a β降解酶(例如胰岛素降解酶)的影响。因此,除了显示特定的o糖基化修饰如何在分子水平上影响A β(42)聚集外,我们的研究还提供了强大的实验工具,以支持进一步研究PTMs如何影响A β(42)原纤维聚集和ad相关的神经毒性。
Brain accumulation of amyloid-beta (A beta) peptides (resulting from a disrupted balance between biosynthesis and clearance) occurs during the progression of Alzheimer's disease (AD). A beta peptides have diverse posttranslational modifications (PTMs) that variously modulate A beta aggregation into fibrils, but understanding the mechanistic roles of PTMs in these processes remains a challenge. Here, we chemically synthesized three homogeneously modified isoforms of A beta (1-42) peptides bearing Tyr10 O-glycosylation, an unusual PTM initially identified from the cerebrospinal fluid samples of AD patients. We discovered that Oglycans significantly affect both the aggregation and degradation of A beta(42). By combining cryo-EM and various biochemical assays, we demonstrate that a Gal beta 1-3GalNAc modification redirects A beta(42) to form a new fibril polymorphic structure that is less stable and more vulnerable to A beta-degrading enzymes (e.g., insulin-degrading enzyme). Thus, beyond showing how particular O-glycosylation modifications affect A beta(42) aggregation at the molecular level, our study provides powerful experimental tools to support further investigations about how PTMs affect A beta(42) fibril aggregation and AD-related neurotoxicity.